Benztropine Mesylate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Benztropine Mesylate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 01/27/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-970-02
- Dosage Form
- Injection
- Presentation
- Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)
- Initial Posting
- 01/27/2026
- Revised Date